Patheous Health, backed by private equity firm NewSpring Capital, announced on May 24 its acquisition of Carolina Speech Pathology for an undisclosed price. This deal expands the company’s mobile dysphagia imaging and education service to 18 states, according to the press release.
This is Patheous Health’s second acquisition since April 2020, when the company acquired MBS Envision, a leading innovator in feeding and swallow health for diagnostics and therapeutics. The deal also marks the 31st Behavioral Health Care deal of 2023, according to data captured in the LevinPro HC database.
Since 1996, Carolina Speech Pathology has been providing mobile fiberoptic endoscopic evaluation of swallow (FEES) study services and is a leading FEES and education resource for senior care. The company is headquartered in Apex, North Carolina.
Patheous Health is a leader in dysphagia and swallowing impairment conditions with its integrated dysphagia healthcare platform.
